Pfizer Inc
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 78003.
- Reported value$170.4m
- Positions17
Holdings: 17 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 20 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics IncALLO | COM | 019770106 | 46.9 | 27.5% | 22,032,040 | Unchanged | |
| Celcuity IncCELC | COM | 15102K100 | 29.6 | 17.3% | 295,652 | Unchanged | |
| Arvinas IncARVN | COM | 04335A105 | 27.7 | 16.2% | 3,457,815 | Unchanged | |
| Pyxis Oncology IncPYXS | COMMON STOCK | 747324101 | 19.5 | 11.4% | 7,032,770 | Unchanged | |
| Wave Life Sciences Ltd | SHS | Y95308105 | 10.9 | 6.4% | 1,875,000 | Unchanged | |
| Biohaven Ltd | COM | G1110E107 | 8.0 | 4.7% | 505,645 | Unchanged | |
| Caribou Biosciences IncCRBU | COM | 142038108 | 7.9 | 4.6% | 4,690,431 | Unchanged | |
| Spero Therapeutics IncSPRO | COM | 84833T103 | 5.3 | 3.1% | 2,362,348 | Unchanged | |
| Zentalis Pharmaceuticals IncZNTL | COM | 98943L107 | 3.9 | 2.3% | 953,834 | Unchanged | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 3.6 | 2.1% | 372,904 | Reduced−4,407,497 | |
| Cardiff Oncology IncCRDF | COM | 14147L108 | 3.0 | 1.8% | 2,411,575 | Unchanged | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 2.9 | 1.7% | 538,841 | Reduced−2,300,072 | |
| Agomab Therapeutics NVAGMB | ADS | 00860C102 | 1.0 | 0.6% | 75,000 | Unchanged | |
| Bolt Biotherapeutics IncBOLT | COM NEW | 097702203 | 0.1 | <0.1% | 31,305 | Unchanged | |
| Nextcure IncNXTC | COM NEW | 65343E207 | 0.1 | <0.1% | 44,347 | Reduced−109,007 | |
| Ginkgo Bioworks Holdings IncDNA | CL A NEW | 37611X209 | 0.0 | <0.1% | 2,928 | Unchanged | |
| Senseonics Holdings Inc | COM | 81727U105 | 0.0 | <0.1% | 2,171 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Q32 Bio IncQTTB | COM | 746964105 | 0.0 | 0.0% | 0 | Sold out−101,618 |
Source: SEC EDGAR, Form 13F-HR, accession 0000078003-26-000102 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.